GOLDMAN SACHS GROUP INC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$509,462
-48.7%
129,305
+38.3%
0.00%
Q2 2023$993,916
+45.2%
93,501
+13.8%
0.00%
Q1 2023$684,492
+9.3%
82,172
+21.1%
0.00%
Q4 2022$626,367
-56.5%
67,862
-39.6%
0.00%
Q3 2022$1,441,000
-10.4%
112,266
-7.8%
0.00%
Q2 2022$1,608,000
-33.0%
121,787
+6.8%
0.00%
-100.0%
Q1 2022$2,400,000
-20.8%
114,042
-9.7%
0.00%0.0%
Q4 2021$3,030,000
-31.1%
126,331
-26.9%
0.00%0.0%
Q3 2021$4,395,000
-4.2%
172,749
+26.7%
0.00%0.0%
Q2 2021$4,590,000
-78.8%
136,388
-75.6%
0.00%
-80.0%
Q1 2021$21,687,000
-39.3%
558,373
-3.2%
0.01%
-44.4%
Q4 2020$35,731,000
+883.2%
576,970
+431.7%
0.01%
+800.0%
Q3 2020$3,634,000
+6.5%
108,504
-24.2%
0.00%0.0%
Q2 2020$3,412,000
+610.8%
143,184
+583.3%
0.00%
Q1 2020$480,000
-75.1%
20,956
-69.2%
0.00%
Q4 2019$1,925,000
+93.9%
67,973
+47.2%
0.00%
Q3 2019$993,000
-57.3%
46,187
-42.0%
0.00%
-100.0%
Q2 2019$2,324,00079,6620.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders